Evidence map›Paper›PMID 30538453›Full record

ArticleInternational journal of nanomedicine2018

Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.

Meng-Meng Lu, Yuran Ge, Jing Qiu, Dan Shao, Yue Zhang, Jing Bai, Xiao Zheng, Zhi-Min Chang, Zheng Wang, Wen-Fei Dong and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Innovative Smart Materials in Restorative Dentistry.Journal of functional biomaterials · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Novel Mouth Rinse Displaying Analgesic and Anti-inflammatory Properties: AnAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Treatment of periodontal disease: does drug delivery matter?Frontiers in bioengineering and biotechnology · 2024
    Article
  17. Review
  18. Organically Modified Mesoporous Silica Nanoparticles against Bacterial Resistance.Chemistry of materials : a publication of the American Chemical Society · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Meng-Meng LuDepartment of Oral Implantology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China, cbtang@njmu.edu.cn.
Yuran GeDepartment of Oral Implantology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China, cbtang@njmu.edu.cn.
Jing QiuDepartment of Oral Implantology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China, cbtang@njmu.edu.cn.
Dan ShaoCAS Key Laboratory of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China, stanauagate@outlook.com.
Yue ZhangSchool of Materials Science and Engineering, Southeast University, Nanjing, 211189, China.
Jing BaiSchool of Materials Science and Engineering, Southeast University, Nanjing, 211189, China.
Xiao ZhengDepartment of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun, 130021, China.
Zhi-Min ChangCAS Key Laboratory of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China, stanauagate@outlook.com.
Zheng WangCAS Key Laboratory of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China, stanauagate@outlook.com.
Wen-Fei DongCAS Key Laboratory of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China, stanauagate@outlook.com.
Chun-Bo TangDepartment of Oral Implantology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, 210029, China, cbtang@njmu.edu.cn.
Stomatology Hospital · CNSuzhou Institute of Biomedical Engineering and Technology · CNSoutheast University · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral plaque biofilms pose a threat to periodontal health and are challenging to eradicate. There is a growing belief that a combination of silver nanoparticles and chlorhexidine (CHX) is a promising strategy against oral biofilms. PURPOSE: To overcome the side effects of this strategy and to exert maximum efficiency, we fabricated biodegradable disulfide-bridged mesoporous silica nanoparticles (MSNs) to co-deliver silver nanoparticles and CHX for biofilm inhibition. MATERIALS AND

methodsCHX-loaded, silver-decorated mesoporous silica nanoparticles (Ag-MSNs@CHX) were fabricated after CHX loading, and the pH- and glutathione-responsive release profiles of CHX and silver ions along with their mechanism of degradation were systematically investigated. Then, the efficacy of Ag-MSNs@CHX against

resultsThe obtained Ag-MSNs@CHX possessed redox/pH-responsive release properties of CHX and silver ions, which may be attributed to the redox-triggered matrix degradation mechanism of exposure to biofilm-mimetic microenvironments. Ag-MSNs@CHX displayed dose-dependent antibacterial activity against planktonic and clone formation of

conclusionOur findings constitute a highly effective and safe strategy against biofilms that has a good potential as an oral biofilm therapy.

Indexed as

AnimalsAnti-Bacterial AgentsBiocompatible MaterialsBiofilmsCell DeathChlorhexidineDelayed-Action PreparationsDrug LiberationEpithelial CellsHumansHydrogen-Ion ConcentrationIonsMetal NanoparticlesMiceMicrobial Sensitivity TestsMouthAnti-Bacterial AgentsBiocompatible MaterialsChlorhexidineDelayed-Action PreparationsIonsSilicon DioxideSilverbiocompatibilitybiodegradable mesoporous silica nanoparticlesbiofilmchlorhexidineGSHpH-responsive releasesilver nanoparticles

Identifiers

PMID30538453
PMCPMC6251470
OpenAlexW2901096651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.